GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Scaled Net Operating Assets

CBIH (Cannabis Bioscience International Holdings) Scaled Net Operating Assets : -11.65 (As of Aug. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cannabis Bioscience International Holdings's operating assets for the quarter that ended in Aug. 2024 was $0.05 Mil. Cannabis Bioscience International Holdings's operating liabilities for the quarter that ended in Aug. 2024 was $0.71 Mil. Cannabis Bioscience International Holdings's Total Assets for the quarter that ended in May. 2024 was $0.06 Mil. Therefore, Cannabis Bioscience International Holdings's scaled net operating assets (SNOA) for the quarter that ended in Aug. 2024 was -11.65.


Cannabis Bioscience International Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Scaled Net Operating Assets Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24
Scaled Net Operating Assets
Get a 7-Day Free Trial 516.42 1.56 0.96 - -14.95

Cannabis Bioscience International Holdings Quarterly Data
May09 Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -4.78 -6.84 -11.65

Competitive Comparison of Cannabis Bioscience International Holdings's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Scaled Net Operating Assets falls into.



Cannabis Bioscience International Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cannabis Bioscience International Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in May. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: May. 2024 )
=(Operating Assets (A: May. 2024 )-Operating Liabilities (A: May. 2024 ))/Total Assets (A: May. 2023 )
=(0.056-0.699)/0.043
=-14.95

where

Operating Assets(A: May. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.057 - 0.001
=0.056

Operating Liabilities(A: May. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.136 - 0.254 - 0.183
=0.699

Cannabis Bioscience International Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Aug. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Aug. 2024 )
=(Operating Assets (Q: Aug. 2024 )-Operating Liabilities (Q: Aug. 2024 ))/Total Assets (Q: May. 2024 )
=(0.045-0.709)/0.057
=-11.65

where

Operating Assets(Q: Aug. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.046 - 0.001
=0.045

Operating Liabilities(Q: Aug. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.102 - 0.25 - 0.143
=0.709

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.